first dose: left sore arm; first dose: feverish; first dose: had sweats; first dose: got  very hot; first dose: diarrhea; headache; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 23 year-old female patient received bnt162b2 (BNT162B2), administered in deltoid left, administration date 25Aug2021 18:15 (Lot number: FC3183) at the age of 23 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Anxiety", start date: Mar2021 (ongoing), notes: Verbatim: Anxiety; "ADHD", start date: Mar2021 (ongoing), notes: Verbatim: ADHD; "Covid 19 infection", start date: Jan2021 (unspecified if ongoing), notes: she doesn't know if that has anything to do with it, she does have a history of Covid 19.; "Birth control" (unspecified if ongoing). Concomitant medication(s) included: LEXAPRO taken for anxiety, start date: Mar2021 (ongoing); TAYTULLA taken for contraception, start date: Jun2018 (ongoing); MULTIVITAMIN FOR WOMEN. Vaccination history included: Gsk flu vaccine (GSK Flu Vaccine. After second dose.), administration date: 25Sep2021. The following information was reported: PYREXIA (non-serious) with onset 25Aug2021, outcome "recovered" (27Aug2021), described as "first dose: feverish"; HYPERHIDROSIS (non-serious) with onset 25Aug2021, outcome "recovered" (27Aug2021), described as "first dose: had sweats"; FEELING HOT (non-serious) with onset 25Aug2021, outcome "recovered" (27Aug2021), described as "first dose: got very hot"; DIARRHOEA (non-serious) with onset 25Aug2021, outcome "recovered" (26Aug2021), described as "first dose: diarrhea"; PAIN IN EXTREMITY (non-serious) with onset 26Aug2021, outcome "recovered" (27Aug2021), described as "first dose: left sore arm"; HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "headache". Therapeutic measures were taken as a result of pyrexia, hyperhidrosis, feeling hot, pain in extremity, headache. Therapeutic measures were not taken as a result of diarrhoea.  Additional information: Relatedness of drug to all reaction(s)/event(s): Source of assessment: Primary Source Reporter.  Method of assessment: Global Introspection. Pfizer Covid 19 Vaccine: first dose: had sweats - Related, Pfizer Covid 19 Vaccine: first dose: got very hot - Related, Pfizer Covid 19 Vaccine: first dose: diarrhea - Related, Pfizer Covid 19 Vaccine: first dose: left sore arm - Related. Why was the patient taking Pfizer Covid 19 Vaccine (Verbatim): for protection against COVID 19. Additional Context: Caller states she is calling to report symptoms she's been experiencing after she got both doses of the Pfizer Covid 19 Vaccine. Pfizer Covid 19 Vaccine: First Dose: After the first dose, it wasn't anything too terrible, She states the 25Aug2021, she felt feverish, had sweats, got very hot then the next day, 26Aug2021, she had diarrhea throughout the day and had a left sore arm, other than that, it all lasted until the 26th at night and she was fine from the 27Aug2021 on. Confirms all symptoms ended 27Aug2021, she recovered completely and all symptoms are not serious. She states she didn't take anything to treat it, she went all natural. She states she had to call out today, she missed yesterday and today because of the symptoms. Treatment: She states her symptoms are not getting worse, she is hoping another day and she will start feeling better. She has been taking extra strength Tylenol 500mg, took it three times yesterday, she hasn't taken anything today. She took Nyquil yesterday to help her sleep because she had such a bad headache she couldn't even look at a computer screen. Confirms all symptoms are not serious. Pfizer Covid 19 Vaccine: Causality: Confirms yes for all symptoms. 5. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available): None. 6. Additional Vaccines Administered on Same Date of the Pfizer Suspect. If applicable, list all vaccines administered on same date with the Pfizer vaccine considered as suspect: None. AE did not require a visit to Emergency Room, Physician Office. 9. Prior Vaccinations (within 4 weeks) If applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s): None. 10. AE(s) following prior vaccinations: None. Dose number 2. Date: 15Sep202118:30. Route of Administration: Left deltoid intramuscular. Lot/Expiry: FF2587. Drug name: Taytulla 1 mg / 20 mg. Drug name: Womens vitamins, Start date: +10Years.  Follow-up attempts completed. No further information expected.